Choosing a prosthetic limb shouldn’t feel like guesswork.

‍
Yet for many people, it does — a high-stakes decision involving devices that can cost as much
as a car, with limited opportunity to “try before you buy.” That’s the problem Humotech is
solving.

‍
Based in Pittsburgh, Humotech develops wearable robotic systems — including prosthetics and
exoskeleton technologies — designed to help individuals regain mobility and independence.
But its real breakthrough lies in how those devices are selected.
Enter the prosthetic foot emulator.

‍
Much like an eye exam where patients test different lenses, Humotech’s system allows
individuals with limb loss to experience multiple prosthetic configurations before committing to
one. The platform collects real-time data on performance and comfort, helping clinicians and
patients identify the best fit with confidence.
‍

The implications are enormous.

‍
Each year, hundreds of thousands of prosthetic limbs are prescribed globally, in a market
exceeding $15 billion. Yet poor fit can lead to device abandonment, wasted healthcare dollars,
and diminished quality of life. Humotech’s approach reduces that risk, ensuring patients receive
solutions tailored to their needs from the start.

‍
After more than a decade of research and development — including collaborations with
Carnegie Mellon University and the U.S. Department of Veterans Affairs — the company is

reaching a pivotal moment. Its technology is set to enter clinical settings, bringing its data-
driven approach directly to patients and providers.

For founder Josh Caputo and his team, the mission is deeply personal and practical: restore
mobility, reduce unnecessary costs, and improve outcomes across the healthcare system.
In a world filled with incremental innovation, Humotech stands out by focusing on something
fundamental — helping people move forward, one step at a time.

‍